The global formulation development outsourcing market size was valued at $22.5 billion in 2021, and is projected to reach $51.9 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. The ...

One of the goals of any oral formulation development project is to create a formulation in which the active pharmaceutical ingredient (API) is sufficiently bioavailable to have the desired therapeutic ...

Outsourcing drug development is a growing trend in the pharmaceutical and biotechnology industries. With growing pressure to take potential drugs candidates from discovery to human clinical trials as ...

Optimizing formulation and API synthesis is critical for product success. Technology providers advance chemocatalysis for olefin metathesis and asymmetric reactions in API synthesis. And ...

Plastic has emerged gradually as a viable packaging material, even for sterile products. Acceptance of plastics has been encouraged by blow–fill–seal (BFS) technology, which provides scientific and ...

As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From ...

Poor solubility is a major challenge for drug sponsors, as the development process is often stalled due to a drug candidate's low aqueous solubility, leading to difficulties in formulation and reduced ...

New antibody formats and aggregate-prone, subcutaneously administered protein therapeutics present biopharmaceutical companies with major challenges regarding protein stability and aggregation. At the ...